5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.16▼ | 1.17▼ | 1.21▼ | 1.50▼ | 1.54▼ |
MA10 | 1.16▼ | 1.24▼ | 1.33▼ | 1.53▼ | 1.16▼ |
MA20 | 1.17▼ | 1.37▼ | 1.47▼ | 1.45▼ | 1.04▲ |
MA50 | 1.35▼ | 1.52▼ | 1.49▼ | 1.08▲ | 1.01▲ |
MA100 | 1.48▼ | 1.51▼ | 1.79▼ | 1.00▲ | 1.03▲ |
MA200 | 1.55▼ | 1.74▼ | 1.25▼ | 0.97▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.011▲ | -0.024▼ | -0.043▼ | -0.065▼ | 0.060▲ |
RSI | 28.652▼ | 25.049▼ | 25.742▼ | 46.391▼ | 51.101▲ |
STOCH | 46.445 | 11.343▼ | 7.919▼ | 12.011▼ | 44.960 |
WILL %R | -50.000 | -90.278▼ | -93.333▼ | -98.284▼ | -71.864 |
CCI | 7.926 | -69.644 | -121.808▼ | -117.777▼ | 13.977 |
Friday, June 06, 2025 01:32 PM
Imunon, Inc. (NASDAQ:IMNN), a company operating in the biotechnology sector, is part of key market indexes such as the Top Companies in the NASDAQ Index.
|
Monday, June 02, 2025 07:15 AM
IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Momentum Continues with Presentations at ASCO and ESMO Imunon, Inc. (NASDAQ:IMNN) has a number of important events planned for June 2025 that we ...
|
Monday, June 02, 2025 05:13 AM
IMNN-001's favorable safety profile and enhanced ... in our share price positions us well to potentially meet the $1 NASDAQ listing requirement in the near term. As we prepare for the Phase ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 1.315 | 1.315 | 1.12 | 1.155 | 2,338,129 |
13/06/25 | 1.56 | 1.57 | 1.40 | 1.43 | 1,575,668 |
12/06/25 | 1.66 | 1.67 | 1.51 | 1.62 | 1,474,030 |
11/06/25 | 1.65 | 1.72 | 1.56 | 1.66 | 2,621,556 |
10/06/25 | 1.325 | 2.08 | 1.275 | 1.625 | 11,752,112 |
09/06/25 | 1.40 | 1.438 | 1.32 | 1.33 | 1,997,270 |
06/06/25 | 1.48 | 1.64 | 1.36 | 1.46 | 4,618,740 |
05/06/25 | 1.58 | 1.63 | 1.40 | 1.40 | 3,692,890 |
04/06/25 | 1.81 | 2.00 | 1.65 | 1.70 | 5,104,391 |
03/06/25 | 2.40 | 2.74 | 1.91 | 1.91 | 8,604,094 |
|
|
||||
|
|
||||
|
|